The von Hippel–Lindau (VHL) tumor-suppressor gene, which is mutated in nearly 90% of advanced ccRCC cases, encodes a critical component of an E3-ubiquitin-ligase complex responsible for the oxygen-dependent degradation of HIF-α subunits (13). Here, VHL is linked to neoplasm.